If you are having problems viewing this page, load here

GXPNews.com - FDA News and Announcements - November 23 - November 27, 2009

The once a week newsletter reporting on what's new with the Food and Drug Administration (FDA)

FDA Handbooks - Drug GMP Handbooks  |  Clinical Handbooks  |  Device Handbooks  |  Biological Handbooks

GMP Publications 2010 FDA Regulation Handbooks

FDA.COM Food and Drug Assistance for Industry and Consumers

Distributed by the leader in Federal Regulations, GMP Publications, GXPNews & FDA.COM - RA/QA Editor

Books>Pharma GMPsMedical DeviceClinicalFood-Diet-CosmeticBiologic-Cell-BloodLaboratoryPart 11EU-Can-Misc.

GXP Academy  |  Conferences  |  Discussions  |  FDA.COM Job Board  |  On-Demand Printing - Custom CRFs

New!  -  GLP Master Handbook - 2009 Canadian GMPs - Eudralex Pharmacovigilance Volume 9a Electronic Systems Master Handbook |  Fax Form

Beat the new 2010 Price increase - order your FDA regulation Handbooks today and save

Get a free copy of the 600 page Clinical Master Reference Guide - Click for details

Stay up to date with the Code of Federal Regulations changes - Enter Email:     Archive

Center for Drug Evaluation &
Research (CDER) News
Drug Approvals - Meetings - Links

Center for Biologics Evaluation
& Research (CBER)
Meetings - Links
Center for Device &
Radiological Health (CDRH)
Meetings - Links
Federal Register - Meetings, Notices, &  Rule Changes
CDER News
Drug Approvals
November 23, 2009
  • ABILIFY (aripiprazole) Tablets, Otsuka Pharmaceutical Company, Ltd., Efficacy Supp. w/Clinical Data
  • Altace (ramipril) Tablets, King Pharmaceuticals, Inc., Labeling Revision
  • Caffeine Citrate Oral Solution, Luitpold Pharmaceuticals, Inc., Approval
  • Calcipotriene Topical Solution, Tolmar, Inc., Approval
  • Cefotaxime Sodium Injection, Aurobindo Pharma Ltd., Approval
  • Cleocin Hydrochloride (clindamycin hydrochloride) Capsules, Pharmacia & Upjohn Co., Labeling Revision
  • Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules, Lilly Research Laboratories, Efficacy Supp. w/Clinical Data
  • Ketorolac Tromethamine Ophthalmic Solution, Sun Pharma Global Inc., Approval
  • Lopinavir and Ritonavir Tablets, Cipla Ltd., Tentative Approval
  • Lopressor (metoprolol tartrate) Injection, Novartis Pharmaceuticals Corp., Labeling Revision
  • Lopressor (metoprolol tartrate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
  • Qualaquin (quinine sulfate) Capsules, AR Holding Company, Inc., Labeling Revision
  • REYATAZ (atazanavir sulfate) Capsules, Bristol-Myers Squibb Co., Efficacy Supp. w/Clinical Data
  • SELZENTRY (maraviroc) Tablets, ViiV Healthcare Company, Efficacy Supp. w/Clinical Data
  • Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Company, LLC, Labeling Revision
CDER Meetings
CDER Links
CBER News
CBER Meetings
CBER Links
CDRH News
NONE
 
CDRH Meetings
NONE
 
CDRH Links
This Week CFR Rule Changes
Wednesday - 510, 520, 522,  558 and 201
Monday - 558
Fri, November 27, 2009
RULES - NONE
 
 
NOTICES
Draft Guidance for Industry and Food and Drug Administration Staff:
     Preliminary Timetable for the Review of Applications for Modified Risk Tobacco Products Under the Federal Food, Drug, and Cosmetic Act; Availability
     62329–62330 [E9–28515]   [TEXT]  [PDF]

Meetings:
     Cardiovascular and Renal Drugs Advisory Committee
     62342 [E9–28302]   [TEXT]  [PDF]
 
Thurs, November 26, 2009
RULES - NONE
 
NOTICES - NONE
 
Wed, November 25, 2009
RULES
New Animal Drugs; Change of Sponsor
61516–61517 [E9–28217]   [TEXT]  [PDF]
Organ-Specific Warnings:
     Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use, etc.
     61512–61516 [E9–28296]   [TEXT]  [PDF]
 
NOTICES
Guidance for Industry:
     Residual Solvents in Drug Products Marketed in the United States
     61692–61693 [E9–28247]   [TEXT]  [PDF]
 
Tue, November 24, 2009
RULES - NONE

 
NOTICES - NONE

 
Mon, November 23, 2009
RULES
New Animal Drugs for Use in Animal Feeds:
     Change of Sponsor
     61028–61029 [E9–28009]  
[TEXT]  [PDF]
     Melengestrol; Monensin; Tylosin
     61029–61030 [E9–28019]  
[TEXT]  [PDF]
 
PROPOSED RULES
Animal Food Labeling:
     Declaration of Certifiable Color Additives
     61068–61074 [E9–27984]  
[TEXT]  [PDF]
 
NOTICES
Debarment Orders:
     Anthony W. Albanese
     61151 [E9–28084]   [TEXT]  [PDF]
     Niaja Kane
     61150–61151 [E9–28083]   [TEXT]  
[PDF]
 
 
 

GXP Academy  |  Conferences  |  Discussions  |  FDA.COM Job Board  |  On-Demand Printing - Custom CRFs

New!  -  GLP Master Handbook - 2009 Canadian GMPs - Eudralex Pharmacovigilance Volume 9a Electronic Systems Master Handbook |  Fax Form

The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds leader in Federal Regulations,
GMP Publications, Inc.  & FDA.COM
Tel: 866-GXPNews (or 856-810-7331)  Fax: 856-810-7339
http://www.gmppublications.com / http://www.fda.com    John Cuspilich, Sr. Editor, GXPNews

If you would like to advertise in this eNewsletter, call 856-810-1825